Schepens Eye Research Institute, Massachusetts Eye and Ear, Department of Ophthalmology, Harvard Medical School, Boston, MA, USA.
Schepens Eye Research Institute, Massachusetts Eye and Ear, Department of Ophthalmology, Harvard Medical School, Boston, MA, USA.
Ocul Surf. 2020 Jul;18(3):460-469. doi: 10.1016/j.jtos.2020.05.002. Epub 2020 May 6.
In this study, we quantify Pigment Epithelium-derived Factor (PEDF) secreted by corneal epithelial cells and evaluate its immunomodulatory functions in a murine model of dry eye disease (DED).
We induced DED in female C57BL/6 mice using a controlled environment chamber for 14 days. We quantified mRNA expression of Serpinf1 gene and PEDF protein synthesis by corneal epithelial cells (CEpCs) using RT-PCR and ELISA. CEpCs from normal or DED mice were cultured with IFNγ-stimulated-dendritic cells (DCs) for 24 h, and expression of MHC-II and CD86 by DCs was determined using flow cytometry. Next, we either added recombinant PEDF (rPEDF) or anti-PEDF antibody to co-culture, and DC expression of the above maturation markers was quantified. Lastly, we treated DED mice with either topical rPEDF, anti-PEDF Ab or murine serum albumin (MSA), and DC maturation, expression of pro-inflammatory cytokines, and DED severity were investigated.
Serpinf1 mRNA expression and PEDF protein production levels by CEpCs were upregulated in DED. CEpCs from DED mice exhibited an enhanced suppressive effect on the expression of MHC-II and CD86 by DCs, compared to normal mice. This effect was abolished by blocking endogenous PEDF with anti-PEDF Ab or enhanced by supplementing with rPEDF. Treatment with anti-PEDF antibody blocked the effect of endogenous-PEDF and increased DC maturation, expression of pro-inflammatory cytokines in conjunctivae, and exacerbated disease severity in DED mice. Conversely, topical rPEDF enhanced the suppressive effect of endogenous PEDF on DC maturation, decreased expression of pro-inflammatory cytokines in conjunctivae, and reduced disease severity.
The results from our study elucidate the role of PEDF in impeding DC maturation, and suppression of ocular surface inflammation, explicating a promising therapeutic potential of PEDF in limiting the corneal epitheliopathy as a consequence of DED.
本研究通过定量分析角膜上皮细胞分泌的色素上皮衍生因子(PEDF),并在干眼症(DED)小鼠模型中评估其免疫调节功能。
通过控制环境室使雌性 C57BL/6 小鼠诱导 DED 14 天。使用 RT-PCR 和 ELISA 定量分析角膜上皮细胞(CEpCs)中 Serpinf1 基因的 mRNA 表达和 PEDF 蛋白合成。将正常或 DED 小鼠的 CEpCs 与 IFNγ 刺激的树突状细胞(DC)共培养 24 h,通过流式细胞术检测 DC 中 MHC-II 和 CD86 的表达。接下来,我们向共培养体系中添加重组 PEDF(rPEDF)或抗 PEDF 抗体,并定量分析上述成熟标志物在 DC 中的表达。最后,我们用局部 rPEDF、抗 PEDF Ab 或鼠血清白蛋白(MSA)处理 DED 小鼠,检测 DC 成熟、促炎细胞因子表达和 DED 严重程度。
DED 时 CEpCs 的 Serpinf1 mRNA 表达和 PEDF 蛋白产生水平上调。与正常小鼠相比,DED 小鼠的 CEpCs 对 DC 中 MHC-II 和 CD86 的表达具有更强的抑制作用。用抗 PEDF Ab 阻断内源性 PEDF 或用 rPEDF 补充可消除这种作用。用抗 PEDF 抗体治疗可阻断内源性 PEDF 的作用,并增加 DC 成熟、结膜中促炎细胞因子的表达,从而加剧 DED 小鼠的疾病严重程度。相反,局部 rPEDF 增强了内源性 PEDF 对 DC 成熟的抑制作用,降低了结膜中促炎细胞因子的表达,减轻了疾病的严重程度。
本研究阐明了 PEDF 在抑制 DC 成熟和抑制眼表炎症中的作用,表明 PEDF 在限制 DED 引起的角膜上皮病方面具有潜在的治疗作用。